Publicacións en colaboración con investigadores/as de Consejo Superior de Investigaciones Científicas (21)

2008

  1. Anti-TNF-α therapy modulates resistin in patients with rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 26, Núm. 2, pp. 311-316

  2. Anti-tumour necrosis factor α therapy modulates ghrelin in patients with severe rheumatoid arthritis

    Annals of the Rheumatic Diseases

  3. Carotid intima-media thickness and endothelial function: Useful surrogate markers for establishing cardiovascular risk in patients with inflammatory rheumatic disease

    Arthritis Research and Therapy

  4. Contribution of HLA-DRB1 shared epitope alleles and chronic inflammation to the increased incidence of cardiovascular disease in rheumatoid arthritis: Comment on the article by Farragher et al.

    Arthritis and Rheumatism

  5. Endothelial Dysfunction, Carotid Intima-Media Thickness, and Accelerated Atherosclerosis in Rheumatoid Arthritis

    Seminars in Arthritis and Rheumatism

  6. High-grade inflammation, circulating adiponectin concentrations and cardiovascular risk factors in severe rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 26, Núm. 4, pp. 596-603

  7. Implication of the age in the clinical spectrum of giant cell arteritis

    Clinical and Experimental Rheumatology, Vol. 26, Núm. 3 SUPPL. 49

  8. Reply

    Arthritis Care and Research

  9. Systemic sclerosis in northwestern Spain: A 19-year epidemiologic study

    Medicine, Vol. 87, Núm. 5, pp. 272-280

  10. The Erythrocyte Sedimentation Rate Is Associated with the Development of Visual Complications in Biopsy-Proven Giant Cell Arteritis

    Seminars in Arthritis and Rheumatism, Vol. 38, Núm. 2, pp. 116-123

2007

  1. Atherosclerosis in patients with biopsy-proven giant cell arteritis

    Arthritis Care and Research, Vol. 57, Núm. 8, pp. 1481-1486

  2. Cancer in Biopsy-Proven Giant Cell Arteritis. A Population-Based Study

    Seminars in Arthritis and Rheumatism, Vol. 37, Núm. 3, pp. 156-163